Express News | Lexicon Pharmaceuticals Inc : Jefferies Cuts Target Price to $2 From $2.5

Moomoo 24/7Apr 22 23:54 ET

Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday

U.S. stocks were higher, with the Nasdaq Composite gaining over 100 points on Monday.Shares of Matterport, Inc. (NASDAQ:MTTR) rose sharply during Monday's session.CoStar Group, Inc. (NASDAQ:CSGP) anno

BenzingaApr 22 10:10 ET

Lexicon Pharmaceuticals, Bio-Path Holdings, Protara Therapeutics Among Healthcare Movers

Seeking AlphaApr 22 10:01 ET

Lexicon Pharmaceuticals to Host 2024 Investor Day

Business and scientific updates will be presented by Lonnel Coats, Lexicon's chief executive officer; Jeff Wade, Lexicon's president and chief financial officer.

Globe NewswireApr 18 08:00 ET

Needham Reiterates Hold on Lexicon Pharmaceuticals

Needham analyst Joseph Stringer reiterates Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Hold.

BenzingaApr 11 06:20 ET

Lexicon Pharmaceuticals Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/11/2024 — Needham Reiterates → Hold 05/31/2023 296.04% Citigroup $6 → $8 Maintains Buy 05/30/2023 — Ne

BenzingaApr 11 06:19 ET